127 related articles for article (PubMed ID: 12727306)
1. High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease.
Parsons RB; Smith SW; Waring RH; Williams AC; Ramsden DB
Neurosci Lett; 2003 May; 342(1-2):13-6. PubMed ID: 12727306
[TBL] [Abstract][Full Text] [Related]
2. Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain.
Parsons RB; Smith ML; Williams AC; Waring RH; Ramsden DB
J Neuropathol Exp Neurol; 2002 Feb; 61(2):111-24. PubMed ID: 11853016
[TBL] [Abstract][Full Text] [Related]
3. High Expression of Nicotinamide N-Methyltransferase in Patients with Sporadic Alzheimer's Disease.
Kocinaj A; Chaudhury T; Uddin MS; Junaid RR; Ramsden DB; Hondhamuni G; Klamt F; Parsons L; Parsons RB
Mol Neurobiol; 2021 Apr; 58(4):1769-1781. PubMed ID: 33387303
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide N-methyltransferase catalyses the N-methylation of the endogenous β-carboline norharman: evidence for a novel detoxification pathway.
Thomas MG; Sartini D; Emanuelli M; van Haren MJ; Martin NI; Mountford DM; Barlow DJ; Klamt F; Ramsden DB; Reza M; Parsons RB
Biochem J; 2016 Oct; 473(19):3253-67. PubMed ID: 27389312
[TBL] [Abstract][Full Text] [Related]
5. N-methylation underlying Parkinson's disease.
Matsubara K; Aoyama K; Suno M; Awaya T
Neurotoxicol Teratol; 2002; 24(5):593-8. PubMed ID: 12200190
[TBL] [Abstract][Full Text] [Related]
6. Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation.
Rini J; Szumlanski C; Guerciolini R; Weinshilboum RM
Clin Chim Acta; 1990 Jan; 186(3):359-74. PubMed ID: 2311261
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells.
Xu J; Moatamed F; Caldwell JS; Walker JR; Kraiem Z; Taki K; Brent GA; Hershman JM
J Clin Endocrinol Metab; 2003 Oct; 88(10):4990-6. PubMed ID: 14557485
[TBL] [Abstract][Full Text] [Related]
8. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
Xu J; Capezzone M; Xu X; Hershman JM
Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
[TBL] [Abstract][Full Text] [Related]
9. A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase.
van Haren MJ; Sastre Toraño J; Sartini D; Emanuelli M; Parsons RB; Martin NI
Biochemistry; 2016 Sep; 55(37):5307-15. PubMed ID: 27570878
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-methyltransferase increases complex I activity in SH-SY5Y cells via sirtuin 3.
Liu KY; Mistry RJ; Aguirre CA; Fasouli ES; Thomas MG; Klamt F; Ramsden DB; Parsons RB
Biochem Biophys Res Commun; 2015 Nov; 467(3):491-6. PubMed ID: 26456643
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease: the first common neurological disease due to auto-intoxication?
Williams AC; Cartwright LS; Ramsden DB
QJM; 2005 Mar; 98(3):215-26. PubMed ID: 15728403
[TBL] [Abstract][Full Text] [Related]
12. Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms.
Yan L; Otterness DM; Craddock TL; Weinshilboum RM
Biochem Pharmacol; 1997 Nov; 54(10):1139-49. PubMed ID: 9464457
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease.
Aoyama K; Matsubara K; Kondo M; Murakawa Y; Suno M; Yamashita K; Yamaguchi S; Kobayashi S
Neurosci Lett; 2001 Jan; 298(1):78-80. PubMed ID: 11154840
[TBL] [Abstract][Full Text] [Related]
14. Citrullination Inactivates Nicotinamide- N-methyltransferase.
Nemmara VV; Tilvawala R; Salinger AJ; Miller L; Nguyen SH; Weerapana E; Thompson PR
ACS Chem Biol; 2018 Sep; 13(9):2663-2672. PubMed ID: 30044909
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagy.
Schmeisser K; Parker JA
PLoS Genet; 2018 Sep; 14(9):e1007561. PubMed ID: 30192747
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state.
van Haren MJ; Taig R; Kuppens J; Sastre Toraño J; Moret EE; Parsons RB; Sartini D; Emanuelli M; Martin NI
Org Biomol Chem; 2017 Aug; 15(31):6656-6667. PubMed ID: 28758655
[TBL] [Abstract][Full Text] [Related]
17. Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.
Gearhart DA; Collins MA; Lee JM; Neafsey EJ
Neurobiol Dis; 2000 Jun; 7(3):201-11. PubMed ID: 10860785
[TBL] [Abstract][Full Text] [Related]
18. Mouse nicotinamide N-methyltransferase gene: molecular cloning, structural characterization, and chromosomal localization.
Yan L; Otterness DM; Kozak CA; Weinshilboum RM
DNA Cell Biol; 1998 Aug; 17(8):659-67. PubMed ID: 9726248
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia does not affect global DNA methylation and nicotinamide N-methyltransferase expression in mice.
Bromberg A; Levine J; Belmaker R; Agam G
J Psychopharmacol; 2011 Jul; 25(7):976-81. PubMed ID: 21169389
[TBL] [Abstract][Full Text] [Related]
20. A direct correlation between nicotinamide N-methyltransferase activity and protein levels in human liver cytosol.
Smith ML; Burnett D; Bennett P; Waring RH; Brown HM; Williams AC; Ramsden DB
Biochim Biophys Acta; 1998 Nov; 1442(2-3):238-44. PubMed ID: 9804963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
